YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2023Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment International Journal of Heart Failure
2023Autophagy Enhancers Regulate Cholesterol-Induced Cytokine Secretion and Cytotoxicity in Macrophages Journal of Lipid and Atherosclerosis
2023Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Management of the Underlying Etiologies and Comorbidities of Heart Failure International Journal of Heart Failure
2023Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Advanced and Acute Heart Failure International Journal of Heart Failure
2023Utilization of artificial intelligence for tuberculosis screening in NepalIndian Journal of Tuberculosis
2023The efficacy of treatment for hepatocellular carcinoma in elderly patients Journal of Liver Cancer(대한간암학회지)
2023Plasma Genotyping From the CROWN, ALTA-1L, and ALEX Trials: Can We Speak With One Voice on What to Test, How to Test, When to Test, and for What Purpose? Journal of Thoracic Oncology
2023Adult-onset MELAS syndrome in a 51-year-old woman without typical clinical manifestations: a case reportEUROPEAN HEART JOURNAL-CASE REPORTS
2024Amivantamab monotherapy in relapsed/refractory metastatic colorectal cancer: OrigAMI-1, an open-label, phase 1b/2 study.Journal of Clinical Oncology
2024EAST ASIARoutledge Handbook of Infectious Diseases: A Geographical Guide, Third Edition
2024Health-related quality of life (HRQOL) with pembrolizumab (pembro) plus trastuzumab (tras) and chemotherapy (chemo) in first-line HER2-positive (HER2+) advanced gastric cancer: KEYNOTE-811 trial resultsJournal of Clinical Oncology
2024A phase 1 study of fianlimab (anti-LAG-3) in combination with cemiplimab (anti-PD-1) in patients with advanced ccRCCJournal of Clinical Oncology
2024Livmoniplimab with or without budigalimab in patients with advanced solid tumors: Results from the combination therapy in the urothelial carcinoma dose expansion cohortJournal of Clinical Oncology
2024First safety and efficacy data from phase Ib/IIa study of fostroxacitabine bralpamide (fostrox, MIV-818) in combination with lenvatinib in patients with hepatocellular carcinoma (HCC).Journal of Clinical Oncology
2024Updated efficacy and safety of larotrectinib (laro) in patients (pts) with TRK fusion gastrointestinal (GI) cancer.Journal of Clinical Oncology
2024Myosteatosis on computed tomography as a predictor of therapeutic response to CDK4/6 inhibitors plus aromatase inhibitors in patients with advanced breast cancerJournal of Clinical Oncology
2024Preliminary results from the phase 2 study of AFM24 in combination with atezolizumab in patients with EGFR wild-type (EGFR-WT) non-small cell lung cancer (NSCLC)Journal of Clinical Oncology
2024Phase 1 trial safety and efficacy of ragistomig, a bispecific antibody targeting PD-L1 and 4-1BB, in advanced solid tumorsJournal of Clinical Oncology
2024Neoadjuvant/adjuvant pembrolizumab (pembro) + chemotherapy (chemo) vs pla cebo (pbo) + chemo for gastric/gastroesophageal junction (G/GEJ) adenocarci noma: Major pathologic response (mPR) in KEYNOTE-585Journal of Clinical Oncology
2024ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17).Journal of Clinical Oncology
1234567891011 800

Recent Submissions

  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links